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Abstract
Ethanol treatment on postnatal day seven (P7) causes robust brain cell death and is a model of late
gestational alcohol exposure (Ikonomidou et al., 2000). To investigate the long-term effects of P7
ethanol treatment on adult brain, mice received either two doses of saline or ethanol on P7 (2.5g/
kg, s.c., 2 hours apart) and were assessed as adults (P82) for brain volume (using postmortem
MRI) and cellular architecture (using immunohistochemistry). Adult mice that received P7 ethanol
had reduced MRI total brain volume (4%) with multiple brain regions being reduced in both males
and females. Immunohistochemistry indicated reduced frontal cortical parvalbumin
immunoreactive (PV+IR) interneurons (18-33%) and reduced Cux1+IR layer II pyramidal neurons
(15%) in both sexes. Interestingly, markers of adult hippocampal neurogenesis differed between
sexes, with only ethanol treated males showing increased doublecortin and Ki67 expression (52
and 57% respectively) in the dentate gyrus, consistent with increased neurogenesis compared to
controls. These findings suggest that P7 ethanol treatment causes persistent reductions in adult
brain volume and frontal cortical neurons in both males and females. Increased adult neurogenesis
in males, but not females, is consistent with differential adaptive responses to P7 ethanol toxicity
between the sexes. One day of ethanol exposure, e.g. P7, causes persistent adult brain
dysmorphology.
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Fetal alcohol spectrum disorders (FASD) is a group of conditions in which in utero ethanol
exposure causes persistent cognitive and behavioral disturbances with or without
craniofacial abnormalities (Barr and Streissguth, 2001; Mattson et al., 1997). Brain
dysfunction can include IQ reductions, hyperactivity, learning deficits and epilepsy and
seizures (Bell et al., 2010; Kodituwakku, 2007; Mattson and Riley, 1998). FASD is
common, with one study estimating that the prevalence of FASD in the US may be as high
as 2-5% (May et al., 2009). Neuroimaging studies using Magnetic Resonance Imaging
(MRI) have reported reductions in total brain volume with certain brain regions including
the corpus callosum, hippocampus , cerebellum and caudate being particularly affected
(Norman et al., 2009). Since the prevalence of this disorder is high, and the complications
can be severe, it is important to better understand the neurostructural deficits associated with
FASD. Rodent studies can be used to model certain features of FASD to study the structural
effects of ethanol on the developing brain. We have employed an ethanol treatment
paradigm in mice during the first postnatal week. This is an age when neurodevelopment is
ongoing, but craniofacial development has completed.
The first postnatal week of life in rodents is considered analogous to the third trimester of
human pregnancy (Dobbing and Sands, 1979). Several studies have utilized various ethanol
exposure paradigms to find that ethanol causes robust neurodegeneration in multiple brain
regions of rodents during the first week of postnatal life (Bonthius and West, 1990;
Dikranian et al., 2005; Goodlett and Eilers, 1997; Ikonomidou et al., 2000; Olney et al.,
2005; Olney et al., 2002a). Ikonomidou et al. found that one day of ethanol treatment on
postnatal day 7 (P7) (2.5g/kg s.c., 2 hours apart) caused robust neuronal cell death in
multiple brain regions, with the cortical regions showing substantial vulnerability to toxicity
at this developmental age (Ikonomidou et al., 2000). The neurotoxic effects of ethanol were
thought to be due to the NMDA receptor antagonistic properties of ethanol leading to
caspase-3 activation and apoptotic cell death (Ikonomidou et al., 1999; Olney et al., 2002a).
Consistent with these observations, we have shown previously that NMDA receptor
antagonism on P7 using MK801 results in a persistent loss of parvalbumin interneurons and
layer V pyramidal neurons in the adult (P80) medial prefrontal cortex (mPFC) (Coleman et
al 2009). However, the long-term effects of this P7 ethanol treatment paradigm on the adult
brain, and whether it causes structural alterations similar to those found in FASD has not
been elucidated. In this study we have investigated the long-term effects of P7 ethanol on
the adult brain structure using structural MRI and immunohistochemistry.
The use of structural MRI to assess changes in rodent brain structure is a novel application
of this historically clinical technique. Recently, structural MRI has been to investigate the
acute effects of early gestational ethanol exposure (GD7, GD8, or GD10) on development,
demonstrating the utility of this technique to study FASD (Godin et al., 2010; O’Leary-
Moore et al., 2010; Parnell et al., 2009). O’Leary-Moore et al have also begun to investigate
the effects of early gestational ethanol on the adolescent brain (O’Leary-Moore et al., 2011).
However, to our knowledge no study has used a MRI in a model of FASD to study the long-
term effects on the adult brain. This is the first study to our knowledge that uses structural
MRI to assess changes in adults in a mouse model of late gestational ethanol exposure.
Since P7 ethanol treatment causes robust neuronal death, we hypothesized that reductions in
brain volume would be detected using MRI. We further hypothesized that volume reductions
would be associated with neuron losses that could be detected by immunohistochemistry.
Since one day of ethanol exposure was found to cause significant cortical damage on P7
(Ikonomidou et al., 2000), and we have previously shown persistent neuron loss in the
mPFC following P7 MK801 treatment (Coleman et al., 2009), we chose to focus on changes
in the numbers of parvalbumin interneurons and pyramidal neurons in the frontal cortex. In
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this study we have measured layer II pyramidal neurons rather than layer V pyramidal
neurons as in our previous study, since layer II pyramidal project contralaterally to
contribute to the volume of the corpus callosum (Molyneaux et al., 2009). Since we
measured corpus callosum volume with MRI, this enabled a comparison of corpus callosum
volume and layer II callosal projection neuron density.
Alcohol is known to have robust effects on hippocampal neurogenesis. We have shown
previously in adult male rats, that ethanol exposure reduces both the number and dendritic
growth of newborn neurons in the dentate gyrus (He et al., 2005). Following a 4-day ethanol
binge in adult male rats, we have found an immediate impairment in neurogenesis, followed
by a wave of enhanced neurogenesis that persists for only two weeks after treatment (Nixon
and Crews, 2004). Ethanol treatment in rats during the first week of postnatal life has also
been shown to have long-lasting effects on hippocampal neurogenesis; however, there are
some differences reported in the literature. Miller et al. made observations similar ours in
adults, finding increased numbers of dentate gyrus hippocampal neurons at P30-35 after
ethanol treatment between P4 and P12 (Miller, 1995). Ieraci and Herrara found that P7
ethanol treatment (5mg/kg) in CD1 mice was associated with reduced neurogenesis later in
adult life (P147) using BrdU and doublecortin staining dorsally (−1.22 to −1.84 mm from
bregma) but ventrally (−3.52 to −3.88 mm from bregma) (Ieraci and Herrera, 2007).
Klintsova et al. found no differences in hippocampal cytogenesis in male rats at P50 and less
survival of new neurons using BrdU labeling at P80 after ethanol treatment from P5-P9
(Klintsova et al., 2007), while Helfer et al. did not see any differences in the density of BrdU
+ neurons in the dentate gyrus at P72 in rats following prenatal ethanol treatment (5.25g/kg/
day, from P4-9) (Helfer et al., 2009). Therefore, the long-term effect of ethanol exposure
during the first postnatal on adult neurogenesis is unclear and may vary across rodent
species. We studied the effect of P7 ethanol treatment on hippocampal dentate neurogenesis
in C57BL/6 mice at P80 using Ki67 and doublecortin (DCX) in a more central region of the
dentate gyrus that was not investigated by Ieraci and Herrera (−2.3 to −3.08 from bregma).
We also investigated both male and female mice to determine whether there are gender-
specific effects.
We found that P7 ethanol treatment caused a persistent reduction in adult total brain volume
using MRI. Volume reductions were found in almost all brain regions measured. Volume
reductions in the cortex and corpus callosum were associated with reductions in frontal
cortical parvalbumin interneurons and layer II medial prefrontal pyramidal neurons (callosal
projection neurons) measured using immunohistochemistry. Surprisingly, adult males that
received P7 ethanol showed increased adult hippocampal neurogenesis, evidenced by
increased doublecortin immunoreactivity and Ki67 immunolabeled cells in the dentate
gyrus. These findings reveal that P7 ethanol treatment results in structural deficits that
persist into adulthood. This suggests that human maternal ethanol consumption during the
third trimester may have long-term effects on brain volume and cellular architecture.
Methods
Animal Treatment
Pregnant C57BL/6 mothers were ordered from Charles River (Raleigh, NC). Offspring were
treated as shown in Figure 1. Pups were given two injections of either saline or ethanol
(20%w/v, 2.5g/kg, s.c. at the area of the neck and the back) two hours apart on P7 in order to
reproduce the ethanol administration method described previously (Ikonomidou et al.,
2000). Both groups of mice were handled identically, and removed from their mother for the
same amount of time. This treatment regimen produces blood alcohol concentrations
(BACs) that are above 200 mg/dl (Ikonomidou et al., 2000), and produces pronounced brain
cell death on P7 in both mice and rats (Ikonomidou et al., 2000; Olney et al., 2002b). The
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total dose is 5 gm/kg. A total of 26 mice (11 control and 15 ethanol) were used for this
study. Previously we found brain region specific changes in adult brain volume using a less
neurotoxic treatment (adolescent ethanol treatment) with smaller sample sizes (control = 10,
ethanol = 8) (Coleman et al., 2011). Thus, we expected adequate power to detect region
specific changes in volume.
Pregnant mice were followed and litters normalized to 10 at birth. Body weights were taken
throughout early life. There was no significant main effect of treatment on weight between
P7 and P22 (F=2.194, p=0.15; Supplemental Figure 1). A transient decrease in body weight
on P8 was not statistically significant (p=0.27, t-test). Mice were weaned and separated by
gender on P21. Mice were anesthetized and sacrificed by perfusion with 4%
paraformaldehyde as adults on P80 for postmortem brain imaging and
immunohistochemistry as described previously (Coleman et al., 2009; Qin et al., 2007).
Adult postmortem MRI brain imaging
Postmortem brains were prepared and underwent magnetic resonance imaging (MRI) as
described previously (Coleman et al., 2011). Whole mouse skulls were scanned at the UNC
Biomedical Research Imaging Center (BRIC) using a dedicated 9.4T Bruker small animal
scanner. Images (0.12mm × 0.12mm × 0.12mm) were acquired using the following diffusion
weighted 3D RARE sequence: TR=0.7s, TEeff =23.662ms, Rare Factor = 3, RARE echo
spacing = 11.3067ms, diffusion gradient time δ=6ms, diffusion gradient separation Δ =
12.422, b value = 1000s/mm2, matrix size = 200×125×80, FOV=24.0mm × 15mm × 9.6mm.
Images were computed from reconstructed diffusion tensor data and were segmented for
volumetric analysis. This sequence allowed for the collection of both structural volumetric
and diffusion data. In this study only structural volume changes are reported. Brain regions
were segmented automatically using a previously established atlas-based method (Lee et al.,
2009). The Brookhaven National Library 3-D MRI Digital Atlas Database of the adult
C57BL/6 mouse (www.bnl.gov/medical/RCIBI/mouse) was used for the automatic
segmentation of this dataset. Blinded investigators subsequently corrected segmentation
errors manually.
Immunohistochemistry
Immunohistochemical analysis was performed as described previously (Coleman et al.,
2009; Crews et al., 2004). Briefly, 40 μm sections were incubated with 0.6% H2O2 for 30
minutes to remove endogenous peroxidase activity. After washes, sections were incubated
with one of the following primary antibodies: Parvalbumin (1:1000, overnight, Sigma),
Doublecortin (1:400, 48hr, Santa Cruz Biotechnology), Ki67 (1:200, 48hr, Vector Labs),
Cux1 (Santa Cruz, sc-13024). Immunoreactive neurons or pixels per area were counted
using Bioquant Image Analysis Software as described (Coleman et al., 2009; Crews et al.,
2004). For PV, Ki67 and Cux1 immunopositive cells were quantified using an unbiased
stereologic method, as described previously (Crews et al., 2004; Nixon and Crews, 2002;
West et al., 1991). Briefly, a one-in-six series of sections was collected, an x–y grid was
placed randomly on the section and an optical dissector thickness was used for counting in
the z-axis. Data is presented as +IR cells per region of interest area (mm2). The boundaries
of the frontal cortex including M1 motor, M2 motor and the medial prefrontal cortex were
defined using the mouse brain atlas (Franklin and Paxinos, 2001) as described previously
(Coleman et al., 2009; Grobin et al., 2003). Briefly, the anterior and posterior boundaries of
the frontal cortex were identified using the appearance of the forceps minor corpus callosum
(bregma 1.98) and the genu of the corpus callosum (bregma 1.1) respectively. The medial
prefrontal cortex included the anterior cingulate, the infralimbic and limbic cortices as
described previously (Coleman et al., 2009; Grobin et al., 2003).
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For DCX+IR, pixel density is used since neuroprogenitor processes are included in the
quantification. Images were captured by using an Olympus BX50 Microscope and video
camera linked to a computer. The microscope, camera, and software were background
corrected and normalized to preset light levels to ensure fidelity of data acquisition. Each
section of a one-in-six series containing immunopositive cells was video captured. The
dentate gyrus (bregma −2.3 to −3.08), is circumscribed in each section for region of interest
area quantification. The density of immunopositive-pixels was analyzed by taking a pixel
count within the circumscribed region. The outlined area [in square millimeter (mm2)] was
determined, and staining density was calculated by dividing the pixel count by the overall
area (pixels per square millimeter). The region of interest area was calculated to assure
equivalent areas were quantified. For all analyses both hemispheres were assessed and
averaged for each section. The 4-5% decrease in overall brain volume found with MRI did
not alter region of interest areas or cell density quantification.
MRI brain structural volume statistics
Student t-tests were performed on whole brain and regional volume measurements. For brain
regional assessments, t-tests followed by a false discovery rate (FDR) analysis were
employed to ascertain statistical significance while accounting for type II errors that may be
caused by multiple comparisons. The FDR method reports a q-value, which is used to
calculate the number of false positives expected. The q values were calculated using the Q-
value module in the R for Windows Software © R Development Core Team 1995-2009. The
following formula was then used to determine the chance of detecting false positives:
likelihood of a false positive = qtarget × (# of regions with qcalculated ≤ qtarget)/# of tests. The
threshold for significance was set such that the likelihood of detecting a false positive would
be less than 0.025. For this data set, this corresponded to a q-value < 0.032.
Immunohistochemistry statistics
A Student’s t-test was employed to determine statistical significance between treatment and
control groups. A p-value less than 0.05 was considered significant. When assessing
parvalbumin immunoreactive neurons in the adult mPFC, the effect of P7 ethanol treatment
at two locations within the mPFC was analyzed using a 2-way ANOVA with the effect of
treatment (vehicle or ethanol) and location (defined as distance from bregma) assessed in the
analysis.
Results
P7 Ethanol treatment reduces adult brain volume measured by MRI
Ethanol treatment on P7 is known to cause cell death in multiple brain regions (Ikonomidou
et al., 2000). It is not clear how this impacts adult brain. We treated pups at P7 and assessed
adult total brain volume using structural MRI brain images. This ethanol treatment did not
have a significant effect on body weight between ages P7 and P22 (F1,40=2.194, p=0.15;
Supplemental Figure 1). There was a transient decrease in body weight on P8 following
treatment that did not reach statistical significance. There were no significant differences in
total brain volume between control males and females, being 440 mm3 and 450 mm3, in
males and females respectively. However, P7 alcohol treatment did reduce adult brain
volume in both males and females. A comparison of P7 ethanol treated mice including both
sexes indicates a reduction of about 5% in total brain volume due to P7 ethanol treatment,
compared to litter-matched controls (Figure 2B). This reduction in total brain volume was
seen in both males and females (4.4%, p<0.007 and 5.95%, p< 0.0001 respectively, N=11
control, 15 ethanol). When analyzing the effect of P7 ethanol on total brain volume in adults
in conjunction with sex (2 × 2 ANOVA), there was a significant main effect of treatment
(F1,23 = 35.87, p<0.0001) but there was not a significant main effect of gender (F1,23 = 1.77,
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P=0.20) on total brain volume. Thus, P7 ethanol treatment reduces adult whole brain
volumes.
To investigate brain region specific effects of P7 ethanol treatment, images were segmented
into multiple regions of interest and normalized to the average volume of litter-matched
controls. The volumes of most brain regions were reduced except for the olfactory bulb,
cerebellum, and inferior colliculi (Table 1). This shows that the volumes of some regions
were preserved following the treatment, and that the sample sizes in this study were
sufficient to detect region specific changes. Fourteen of the brain regions showed significant
volume reductions ranging from 4.09% to 6.92% (*p<0.05, q<0.03; **p<0.01, q<0.03;
***p<0.001, q<0.03; p-values from t-test and q values from FDR). In general, the volumes
of most brain regions were reduced proportionally by P7 ethanol, such that the percentage of
the total brain volume of each region was unchanged by P7 ethanol treatment (Tables 2 and
3) consistent with nearly global changes in volume due to ethanol treatment. Post-hoc
analyses revealed variances in the volumes of some regions between males and females. For
instance, seven brain regions showed significant reductions in females, but not males.
However, the magnitudes of the volume changes were similar in both sexes (Tables 2 and
3). Differences in the sample sizes between males (N=5 control, 6 ethanol) and females
(N=7 control, 9 ethanol) likely accounts for these differences, suggesting similar effects on
P7 ethanol on adult brain volume in both sexes. Thus, P7 ethanol treatment decreases adult
cortical, hippocampal, forebrain, midbrain and other brain regional volumes in both males
and females.
P7 Ethanol treatment results in a reduction in the number of parvalbumin positive
interneurons and layer II pyramidal neurons in the adult frontal cortex
In previous studies we found that P7 dizocilpine treatment, an NMDA receptor antagonist
that mimics P7 ethanol neurotoxicity (Ikonomidou et al., 2000), resulted in persistent
reductions in adult frontal cortical neurons (Coleman et al., 2009). Since P7 ethanol reduces
the volume of the adult neocortex, we investigated adult frontal cortical neuron density
using immunohistochemistry specific for a subtype of inhibitory cortical interneurons, e.g.
parvalbumin immunoreactive (PV+IR) cells, and cortical layer 2 pyramidal cells, e.g. Cux1
immunoreactive (Cux1+IR) cells.
P7 ethanol treatment results in a persistent reduction in cortical parvalbumin interneurons
focusing within the frontal cortex. Immunohistochemical staining showed visible reductions
of PV+IR neurons in the frontal cortex (Figure 3A). Parvalbumin interneuron staining was
reduced in both M2 frontal motor cortex (Figure 3B, 31%, ***p<0.001) and the medial
prefrontal cortex (Figure 3C, 19%, 2-way ANOVA F1,42=7.08, *p<0.02, main effect of
treatment, N = 9 control, 15 ethanol).
MRI volume investigation revealed that P7 ethanol caused a reduction in volume of the
corpus callosum in adults (Table 1). Therefore, we examined whether layer II callosal
projection neurons were persistently reduced as a result of P7 ethanol treatment. We
performed Cux1 immunohistochemistry to identify layer II pyramidal neurons. There was a
visible reduction in Cux1 immunoreactive cells in the medial prefrontal cortex (Figure 4A).
Quantification revealed approximately a 15% reduction in the density of Cux1 cells (Figure
4B, p<0.001, N=8 control, 9 ethanol). Both male and female adults showed similar
reductions. Interestingly, there were no reductions in Cux1 pyramidal neurons seen in the
M2 frontal motor cortex (p=0.98, data not shown). This suggests that mPFC layer II
pyramidal neurons are vulnerable to ethanol neurotoxicity on P7.
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P7 Ethanol results in increased cell proliferation and neuronal DCX expression in males
but not females
We have found previously that alcohol can alter neurogenesis in adult males causing an
initial reduction in neurogenesis followed by a compensatory increase in neurogenesis up to
14 days after the end of alcohol treatment (Nixon and Crews, 2004). Using DCX and Ki67
immunohistochemistry, we investigated whether P7 ethanol altered adult neurogenesis.
DCX+IR was visibly increased in adult male mice that received P7 ethanol (Figure 5A).
This corresponded to a 52% increase in DCX-IR pixels/mm2 (Figure 5B, N=4 control, 6
ethanol). There was no difference in the areas of dentate gyrus measured between groups
(p=0.22, not shown). The entire neuroprogenitor contains doublecortin, such that DCX+IR
reflects both the number of DCX+IR cells and the dendritic processes. We also performed
immunohistochemical staining for Ki67, a marker of cell proliferation. Ki67
immunoreactivity was increased in adult males that received ethanol on P7 (Figure 6A).
When quantified, this corresponded to a 57% increase in Ki67+cells per area (Figure 6B,
N=4 control, 6 ethanol). These observations indicate that increased cell proliferation and
immature neuronal outgrowth are found in the dentate gyrus of the hippocampus of adult
males exposed to ethanol on P7.
Interestingly, postnatal day 7 ethanol treatment did not result in a change in DCX expression
in the dentate gyrus of adult females (Figure 7, N=6 control, 6 ethanol). There was no
difference in the area of the dentate gyrus measured between both groups (not shown). This
is clearly different than our observations in adult males that received ethanol treatment on
P7. Ki67 expression was visualized in the dentate gyrus using immunohistochemistry
(Figure 8A). Consistent with DCX measurements in adult females, there were no changes in
Ki67 expression in adult females regardless of P7 ethanol treatment (N=6 control, 6
ethanol). Quantification revealed similar numbers of Ki67+ neurons in both adult females
groups (Figure 8B). Though in certain species such as the rat and vole, the estrous cycle and
the level of endogenous estrogen have been found to regulate hippocampal neurogenesis, it
has been found in the C57BL/6 mouse that neither the estrous cycle nor ovarectomy alter the
rate of adult hippocampal neurogenesis (Lagace et al 2007). Our findings are consistent with
no changes in basal neurogenesis between males and females in C57BL/6 mice. Thus, the
differences in adult hippocampal DCX and Ki67 expression between males and females
following P7 ethanol that we have observed are not explained by the estrous cycle or
endogenous estrogen, but rather some other gender specific differences in the response to P7
ethanol exposure.
Discussion
The developing brain is sensitive to ethanol neurotoxicity during the early postnatal period.
We report for the first time a reduction in total brain volume detected by MRI in adult mice
that received P7 ethanol. This observation is consistent with human brain imaging studies
and demonstrates the translational utility of this technique. The reduction in brain volume
was observed in a majority of the brain regions that were investigated (14 out of 18). Since
there were no differences in body weight between the two groups by postnatal day 22,
ethanol effects are likely due to specific effects on the brain rather than effects on overall
body size. The nearly global reduction in brain volume may be somewhat broader than what
is observed in humans. Human imaging studies have found reductions in total brain volume
as well as specific significant reductions in the cortex, corpus callosum, caudate, cerebellum
and hippocampus in individuals with FASD (for review see Norman et al 2009). The
potentially broader effect seen in rodents may be related to differences in the rate of
development between humans and rodents. Developmental events occurring on postnatal
day 7 in rodents are occurring during the third trimester in humans (Dobbing and Sands,
1979). However, human pregnancy is 266 days versus 28 days (including in utero and first
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postnatal week) in mice. Thus, this study may be a model of drinking during several days of
the third trimester of pregnancy. The ability to detect persistent brain volume changes using
MRI demonstrates the utility of this technique and its usefulness in comparing human and
rodent studies. Further immunohistochemical investigations also found reductions in cortical
neurons.
Several studies have found neuron death acutely after the P7 alcohol treatment paradigm
(Ikonomidou et al., 2000; Olney et al., 2005; Olney et al., 2002a). We found persistent
reductions in cortical parvalbumin interneurons and layer II pyramidal neurons. These
findings are consistent with our previous work in which treatment with the NMDA receptor
antagonist MK801 on P7 caused persistent reductions in cortical parvalbumin interneurons
and layer V pyramidal neurons (Coleman et al., 2009). This suggests that the loss of neurons
contributes to the persistent reduction in brain volume measured using MRI. Other cellular
elements as well including dendritic arbors, myelin, and glia could potentially be affected in
adulthood by P7 ethanol, and these structural elements should be investigated. Also, region
specific effects were observed. We found that layer II cortical projection pyramidal neurons
were reduced in the medial prefrontal cortex, but not in the M2 motor region. This suggests
that pyramidal neurons in the mPFC are more vulnerable to the long-term effects of late
gestational ethanol toxicity. Layer II pyramidal neurons may play a role in the
pathophysiology of FASD. Layer II pyramidal neurons comprise the majority of the cortico-
cortical projection neurons, which send axons contralaterally and comprise the corpus
callosum (Molyneaux et al., 2009). Human imaging studies in children with FASD have
found reductions in the volume of the corpus callosum (Autti-Ramo et al., 2002; Bhatara et
al., 2002; Sowell et al., 2001). We also observed a persistent reduction in the volume of the
adult corpus callosum following P7 ethanol treatment, consistent these human studies. A
loss of layer II pyramidal neurons could be contributing to the observed volume reduction of
corpus callosum in FASD. We also found persistent reductions in parvalbumin interneurons
in the adult mPFC and the M2 motor region after P7 ethanol treatment. The mPFC is
important for cognitive functions including attentional set shifting and cognitive function
(Floresco et al., 2008; Stefani and Moghaddam, 2005). Attentional deficit with hyperactivity
disorder is the most common co-morbordity associated with FASD (Bhatara et al., 2006;
Chiodo et al., 2010; Fryer et al., 2007; Kodituwakku et al., 2006). These studies indicate that
late gestational ethanol causes persistent reductions in adult layer II pyramidal neurons and
parvalbumin interneurons, and that the role of these neurons in the pathophysiology of
FASD should be investigated.
We also observed changes in adult neurogenesis after P7 ethanol treatment. Treatment with
ethanol on P7 caused an increase in neurogenesis in adult (P80) males evidenced by both
increased doublecortin staining and Ki67 expression. This observation shows an
enhancement of neurogenesis in adult (P80) mice following P7 ethanol treatment that
persists for several weeks longer than we have observed previously following binge ethanol
treatment in adult rats (Nixon and Crews, 2004). Interestingly, we did not observe an
enhancement of neurogenesis in adult female mice. The reason for this difference is not
clear. However, it is likely not attributable to the estrous cycle since neurogenesis in the
C57BL/6 mouse does not fluctuate with the estrous cycle as it does in other rodents, but is
rather due to some other unknown difference between the two sexes in this species (Lagace
et al., 2007). There may have been differences in locomotor activity between males and
females. Ethanol treatment on P7 has been found to cause hyperactivity in adult mice at P60
(Ieraci and Herrera, 2006) and exercise is known to increase neurogenesis in the dentate
gyrus following ethanol treatment (Crews et al., 2004; Helfer et al., 2009). It is possible that
the male mice that received ethanol were more active in their cages, resulting in increased
hippocampal neurogenesis. Our findings are consistent with those of Miller et al., who found
that early postnatal ethanol treatment in rats (between P4 and P12) was associated with
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increased numbers of dentate gyrus hippocampal neurons at P30-35 (Miller, 1995).
However, Ieraci and Herrara, found that P7 ethanol treatment (5mg/kg) in CD1 mice was
associated with reduced neurogenesis later in adult life (P147) in dorsal (−1.22 to −1.84 mm
from bregma) but not ventral (−3.52 to −3.88 mm from bregma) dentate gyrus, and found no
differences between genders (Ieraci and Herrera, 2007). We used C57BL/6 mice rather than
CD1 mice and studied the region of the dentate gyrus between that was more centrally
located (−2.3 to −3.08 from bregma), which might contribute to the differences between our
findings. Also, neurogenesis is known to diminish substantially with age (He and Crews,
2007). Thus, it is also possible that the enhancement of neurogenesis that we observed in
adult males at P80 diminishes with advanced age, and was therefore not detected by Ieraci
and Herrera at P147. Other neurotoxic insults on P7 have been shown to cause increased
neurogenesis in adulthood. Dong et al. found increased neurogenesis using BrdU labeling in
the CA3 region of hippocampus of adult female rats (P60) after acute neurotoxicity induced
by P7 kainate treatment (Dong et al., 2003). These findings suggest that there may be a
compensatory mechanism following early-life hippocampal damage. The exact timing and
duration of such a response depends on the nature of the postnatal neurotoxic insult, the
rodent species, gender, and the adult age investigated.
In summary, P7 ethanol causes persistent deficits in adult brain structure that can be detected
by MRI and immunohistochemistry. These observations are consistent with human imaging
studies of FASD. The potential role of persistent losses of pyramidal neurons and
parvalbumin interneurons in FASD should be investigated. Also, future studies should
investigate strategies to reverse or prevent this long-term ethanol-induced neuropathology.
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P7 ethanol treatment with adult (P80) investigation. Mice were treated with 2 ethanol
treatments (2.5g/kg,s.c.two hours apart on P7. Postmortem brain imaging and
immunohistochemistry were performed in adulthood (P80). Key: E – ethanol.
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Reduction in adult total brain volume following P7 ethanol. (A) 3D Renderings of adult
subjects that received either saline or ethanol on P7. Note the global reductions in brain
volume. (B) Adult brain volumes of all subjects. Adult mice that received P7 ethanol
treatment showed approximately a 5% reduction in total brain volume when compared to
litter-matched controls (***p<0.0001, N = 11 control, 15 ethanol)
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Reduction of parvalbumin interneurons in the adult frontal cortex following P7 ethanol
treatment. Mice were given either saline or ethanol (2.5g/kg, i.p.) two times, two hours apart
on P7. Both sexes were pooled. (A) Representative images (40X) of PV+IR staining in the
M2 region of the frontal cortex. Visible reductions in PV+IR are seen. (B) Significant
reduction in PV+IR neuron density in the frontal M2 motor cortex (31%, ***p<0.001). (C)
Significant reduction of 19% in PV+IR neuron density across the medial prefrontal cortex
from 1.1 to 1.8mm distance from bregma (denoted by asterix). 2-way ANOVA, main effect
of treatment F1,42=7.08, *p<0.02, N = 9 control, 15 ethanol). Arrows highlight
representative PV+IR neurons. Scale bars denote 20 microns.
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P7 ethanol reduces Cux1 labeled layer II pyramidal neurons in the medial prefrontal cortex
(mPFC). Adult mice that received ethanol (2.5g/kg, i.p. twice, two hours apart) showed
fewer Cux1 immunopositive neurons in the mPFC (A) Images (40X) showing fewer Cux1
layer II pyramidal neurons in the mPFC (B) Quantification of Cux1 layer II pyramidal
neurons in the mPFC showed approximately a 15% significant reduction in adult mice that
received P7 ethanol (***p<0.001, N=8 control, 9 ethanol). Arrows highlight representative
PV+IR neurons. Scale bars denote 20 microns. Layers I, II/II, and IV are identified using
Roman Numerals at the bottom of the images.
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P7 ethanol alters neurogenesis in adult males. Males that received ethanol (2.5g/kg, i.p.
twice, two hours apart) showed an increase doublecortin (DCX) expression in the dentate
gyrus. (A) Representative images showing increased DCX expression (Scale bars denote
200 microns). High powered images (120X) are also shown in the inserts to highlight the
differences. (B) Quantification of DCX-IR pixels shows a 52% increase in dentate gyrus
DCX expression (**p<0.004). N=4 control, 6 ethanol
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P7 ethanol alters cell proliferation in adult males. Males that received ethanol (2.5g/kg, i.p.
twice, two hours apart) showed an increase Ki67 expression in the dentate gyrus. (A)
Representative images showing increased Ki67 expression in the ethanol group. Scale bars
denote 100 microns. Arrows highlight Ki67+cells. High powered images (120X) are in the
inserts are included. (B) Quantification of Ki67 cells per area showed a 57% increase in
dentate gyrus Ki67 expression (**p<0.004). N=4 control, 6 ethanol. Scale bars denote 100
microns.
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P7 ethanol does not alter neurogenesis in adult females. Females that received ethanol (2.5g/
kg, i.p. twice, two hours apart) showed no change in doublecortin (DCX) expression in the
dentate gyrus. (A) Representative images showing similar DCX expression. High powered
images (120X) in the inserts also show similar DCX expression. (B) Quantification of DCX-
IR pixels no change in dentate gyrus DCX expression (p<0.95). N=6 control, 6 ethanol.
Scale bars denote 200 microns.
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P7 ethanol does not alter cell proliferation in adult females. Females that received ethanol
(2.5g/kg, i.p. twice, two hours apart) showed no change in Ki67 expression in the dentate
gyrus. (A) Representative images showing similar Ki67 expression in both groups. Scale
bars denote 100 microns. High powered images (120X) are in the inserts and also show no
difference. (B) Quantification of Ki67 cells per area showed a similar density of Ki67 cells
in both treatment groups. N=5 control, 6 ethanol.
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Table 1
Regional brain volumes assessment (all subjects)
Region % Difference p-value (t-test) q-value(FDR)
Neocortex −6.37*** 0.0003 0.001
Hypothalamus −6.92*** 0.0003 0.001
Amygdala −6.33*** 0.0005 0.001
Hippocampus −4.75** 0.0010 0.001
Caudate & Putamen −4.40** 0.0010 0.001
Basal Forebrain & Septum −6.62** 0.0011 0.001
Thalamus −4.28** 0.0019 0.002
Internal Capsule −4.28** 0.0019 0.002
Globus Pallidus −4.3** 0.0026 0.002
Central Gray −4.09** 0.0035 0.002
Rest of Midbrain −4.44** 0.0052 0.003
Superior Colliculi −4.17** 0.0074 0.004
Corpus Callosum/Ext Capsule −4.40** 0.0078 0.004
Fimbria −4.82* 0.011 0.006
Brain Stem −5.95* 0.030 0.015
Cerebellum −3.85 0.059 0.028
Olfactory Bulb −4.98 0.23 0.10
Inferior Colliculi +0.26 0.95 0.40
FDR = False discovery rate correction for multiple comparisons
p = t-test probability







(−) reduction in volume
(+) increase in volume
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Table 2
Regional brain volumes in males assessed by MRI









Hippocampus 24.3 ± 0.5 23.6 ± 0.8 5.5 5.6
CC & External capsule 12.9 ± 0.4 12.5 ± 0.3 2.9 2.9
Caudate & Putamen 24.8 ± 0.4 24.3 ± 1.0 5.6 5.7
AC 1.2 ± 0.0 1.2 ± 0.0 0.3 0.3
GP 3.0 ± 0.1 3.0 ± 0.1 0.7 0.7
Internal capsule 2.2 ± 0.1 2.1 ± 0.1 0.5 0.5
Thalamus 24.7 ± 0.5 24.3 ± 1.0 5.6 5.7
Cerebellum 54.0 ± 1.3 52.3 ± 2.3 12.2 12.3
Superior Colliculi 7.9 ± 0.1 7.7 ±0.4 1.8 1.8
Ventricle 1.5 ± 0.1 1.4 ± 0.1 0.3 0.3
Hypothalamus 11.9 ± 0.4 11.3 ± 0.5 2.7 2.7
Inferior colliculi 5.4 ±0.0 5.3 ± 0.3 1.2 1.2
Central Gray 4.2 ± 0.1 4.2 ± 0.1 0.9 1.0
Neocortex 144.7 ± 2.4 140.5 ± 4.1 32.7 33.2
Amygdala 12.8 ± 0.5 12.1 ± 0.3 2.9 2.8
Olfactory Bulb 27.0 ± 1.5 24.0 ± 2.8 6.1 5.7
Brain Stem 49.7 ± 2.1 48.1 ± 4.0 11.2 11.4
Rest of Midbrain 12.2 ± 0.2 11.9 ± 0.5 2.8 2.8
Basal Forebrain & Septum 12.6 ± 0.3 12.1 ± 0.6 2.9 2.9
Fimbria 2.2 ± 0.1 2.1 ± 0.1 0.5 0.5
%TBV = percent of total brain volume
Volumes are presented as mean ± S.D.
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Table 3
Regional brain volumes in females assessed by MRI









Hippocampus 25.4 ± 0.7 23.8 ± 1.1 5.6 5.6
CC & External capsule 13.5 ± 0.5 12.8 ± 0.6 3.0 3.0
Caudate & Putamen 26.1 ± 0.6 24.6 ± 1.0 5.8 5.8
AC 1.2 ± 0.1 1.2 ± 0.1 0.3 0.3
GP 3.2 ± 0.1 3.0 ± 0.1 0.7 0.7
Internal capsule 2.3 ± 0.1 2.1 ± 0.1 0.5 0.5
Thalamus 26.0 ± 0.7 24.4 ± 1.1 5.8 5.7
Cerebellum 55.3 ± 4.6 53.3 ± 3.6 12.3 12.5
Superior Colliculi 8.4 ± 0.2 8.0 ± 0.4 1.9 1.9
Ventricle 1.6 ± 0.1 1.5 ± 0.1 0.3 0.3
Hypothalamus 12.6 ± 0.8 11.5 ± 0.6 2.8 2.7
Inferior colliculi 5.3 ± 0.8 5.4 ± 0.3 1.2 1.3
Central Gray 4.4 ± 0.2 4.2 ± 0.2 1.0 1.0
Neocortex 147.9 ± 5.5 135.9 ± 9.6 32.8 31.9
Amygdala 13.1 ± 0.6 12.2 ± 0.7 2.9 2.9
Olfactory Bulb 26.9 ± 2.5 26.7 ± 3.3 6.0 6.3
Brain Stem 52.2 ± 5.0 48.2 ± 1.4 11.6 11.3
Rest of Midbrain 12.9 ± 0.4 12.1 ± 0.6 2.9 2.9
Basal Fore Brain & Septum 13.1 ± 0.5 12.1 ± 0.8 2.9 2.8
Fimbria 2.3 ± 0.1 2.1 ± 0.1 0.5 0.5
%TBV = percent of total brain volume
Volumes are presented as mean ± S.D.
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